Tapewire

Nasdaq · USD

LBTYA

Liberty Global Ltd.

Export transactions ↓
Tapewire entity
4116
SEC CIK
0001570585
Parsed reports
814

Last 12 months

Inside the activity.

0 purchase rows · 13 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202501
Jan 202600
Feb 202600
Mar 202606
Apr 202600
May 202602
Jun 202604
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 25, 2023 Filed Mar 4, 2024 22:29 UTC Amendment
COLE ANDREWDirector
GrantShare Option C (right to buy) · Derivative 7,150 Not disclosed Strike: $27.85 Not disclosed
Disclosure

SEC source: 0001570585-24-000064 · wk-form4a_1709591350.xml · derivative · entry 10

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,150

Underlying: Class C Common Shares · 7,150 shares

Expires 2027-06-21

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

F2 · derivative.underlying_shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F2 · balance_after: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

Read SEC document
April 25, 2023 Filed Mar 4, 2024 22:29 UTC Amendment
COLE ANDREWDirector
Disposition to issuerShare Option C (right to buy) · Derivative 7,150 Not disclosed Strike: $27.85 Not disclosed
Disclosure

SEC source: 0001570585-24-000064 · wk-form4a_1709591350.xml · derivative · entry 9

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class C Common Shares · 7,150 shares

Expires 2027-06-21

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

F2 · derivative.underlying_shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F2 · balance_after: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

Read SEC document
April 25, 2023 Filed Mar 4, 2024 22:29 UTC Amendment
COLE ANDREWDirector
GrantShare Option C (right to buy) · Derivative 5,840 Not disclosed Strike: $29.64 Not disclosed
Disclosure

SEC source: 0001570585-24-000064 · wk-form4a_1709591350.xml · derivative · entry 8

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,840

Underlying: Class C Common Shares · 5,840 shares

Expires 2026-06-16

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

F2 · derivative.underlying_shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F2 · balance_after: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

Read SEC document
April 25, 2023 Filed Mar 4, 2024 22:29 UTC Amendment
COLE ANDREWDirector
Disposition to issuerShare Option C (right to buy) · Derivative 5,840 Not disclosed Strike: $29.64 Not disclosed
Disclosure

SEC source: 0001570585-24-000064 · wk-form4a_1709591350.xml · derivative · entry 7

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class C Common Shares · 5,840 shares

Expires 2026-06-16

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

F2 · derivative.underlying_shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F2 · balance_after: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

Read SEC document
April 25, 2023 Filed Mar 4, 2024 22:29 UTC Amendment
COLE ANDREWDirector
GrantShare Option A (right to buy) · Derivative 4,412 Not disclosed Strike: $30.14 Not disclosed
Disclosure

SEC source: 0001570585-24-000064 · wk-form4a_1709591350.xml · derivative · entry 6

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,412

Underlying: Class A Common Shares · 4,412 shares

Expires 2028-06-12

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

F2 · derivative.underlying_shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F2 · balance_after: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

Read SEC document
April 25, 2023 Filed Mar 4, 2024 22:29 UTC Amendment
COLE ANDREWDirector
Disposition to issuerShare Option A (right to buy) · Derivative 4,412 Not disclosed Strike: $30.14 Not disclosed
Disclosure

SEC source: 0001570585-24-000064 · wk-form4a_1709591350.xml · derivative · entry 5

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Shares · 4,412 shares

Expires 2028-06-12

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

F2 · derivative.underlying_shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F2 · balance_after: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

Read SEC document
April 25, 2023 Filed Mar 4, 2024 22:29 UTC Amendment
COLE ANDREWDirector
GrantShare Option A (right to buy) · Derivative 3,575 Not disclosed Strike: $28.83 Not disclosed
Disclosure

SEC source: 0001570585-24-000064 · wk-form4a_1709591350.xml · derivative · entry 4

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,575

Underlying: Class A Common Shares · 3,575 shares

Expires 2027-06-21

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

F2 · derivative.underlying_shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F2 · balance_after: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

Read SEC document
April 25, 2023 Filed Mar 4, 2024 22:29 UTC Amendment
COLE ANDREWDirector
Disposition to issuerShare Option A (right to buy) · Derivative 3,575 Not disclosed Strike: $28.83 Not disclosed
Disclosure

SEC source: 0001570585-24-000064 · wk-form4a_1709591350.xml · derivative · entry 3

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Shares · 3,575 shares

Expires 2027-06-21

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

F2 · derivative.underlying_shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F2 · balance_after: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

Read SEC document
April 25, 2023 Filed Mar 4, 2024 22:29 UTC Amendment
COLE ANDREWDirector
GrantShare Option A (right to buy) · Derivative 2,920 Not disclosed Strike: $30.47 Not disclosed
Disclosure

SEC source: 0001570585-24-000064 · wk-form4a_1709591350.xml · derivative · entry 2

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,920

Underlying: Class A Common Shares · 2,920 shares

Expires 2026-06-16

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

F2 · derivative.underlying_shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F2 · balance_after: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

Read SEC document
April 25, 2023 Filed Mar 4, 2024 22:29 UTC Amendment
COLE ANDREWDirector
Disposition to issuerShare Option A (right to buy) · Derivative 2,920 Not disclosed Strike: $30.47 Not disclosed
Disclosure

SEC source: 0001570585-24-000064 · wk-form4a_1709591350.xml · derivative · entry 1

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Shares · 2,920 shares

Expires 2026-06-16

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

F2 · derivative.underlying_shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F2 · balance_after: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

Read SEC document
April 25, 2023 Filed Apr 27, 2023 21:03 UTC
MALONE JOHN CDirector · 10% owner
GrantShare Option C (right to buy) · Derivative 129,974 Not disclosed Strike: $28.94 Not disclosed
Disclosure

SEC source: 0001570585-23-000145 · wf-form4_168262940232649.xml · derivative · entry 10

MALONE JOHN C · CIK 0000937797 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 129,974

Underlying: Class C Ordinary Shares · 129,974 shares

Expires 2028-05-01

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

Read SEC document
April 25, 2023 Filed Apr 27, 2023 21:03 UTC
MALONE JOHN CDirector · 10% owner
Disposition to issuerShare Option C (right to buy) · Derivative 129,974 Not disclosed Strike: $28.94 Not disclosed
Disclosure

SEC source: 0001570585-23-000145 · wf-form4_168262940232649.xml · derivative · entry 9

MALONE JOHN C · CIK 0000937797 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class C Ordinary Shares · 129,974 shares

Expires 2025-05-01

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

Read SEC document
April 25, 2023 Filed Apr 27, 2023 21:03 UTC
MALONE JOHN CDirector · 10% owner
GrantShare Option C (right to buy) · Derivative 64,946 Not disclosed Strike: $34.80 Not disclosed
Disclosure

SEC source: 0001570585-23-000145 · wf-form4_168262940232649.xml · derivative · entry 8

MALONE JOHN C · CIK 0000937797 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,946

Underlying: Class C Ordinary Shares · 64,946 shares

Expires 2027-05-01

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

Read SEC document
April 25, 2023 Filed Apr 27, 2023 21:03 UTC
MALONE JOHN CDirector · 10% owner
Disposition to issuerShare Option C (right to buy) · Derivative 64,946 Not disclosed Strike: $34.80 Not disclosed
Disclosure

SEC source: 0001570585-23-000145 · wf-form4_168262940232649.xml · derivative · entry 7

MALONE JOHN C · CIK 0000937797 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class C Ordinary Shares · 64,946 shares

Expires 2024-05-01

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

Read SEC document
April 25, 2023 Filed Apr 27, 2023 21:03 UTC
MALONE JOHN CDirector · 10% owner
GrantShare Option C (right to buy) · Derivative 60,518 Not disclosed Strike: $31.65 Not disclosed
Disclosure

SEC source: 0001570585-23-000145 · wf-form4_168262940232649.xml · derivative · entry 6

MALONE JOHN C · CIK 0000937797 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,518

Underlying: Class C Ordinary Shares · 60,518 shares

Expires 2026-05-01

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

Read SEC document
April 25, 2023 Filed Apr 27, 2023 21:03 UTC
MALONE JOHN CDirector · 10% owner
Disposition to issuerShare Option C (right to buy) · Derivative 60,518 Not disclosed Strike: $31.65 Not disclosed
Disclosure

SEC source: 0001570585-23-000145 · wf-form4_168262940232649.xml · derivative · entry 5

MALONE JOHN C · CIK 0000937797 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class C Ordinary Shares · 60,518 shares

Expires 2023-05-01

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

Read SEC document
April 25, 2023 Filed Apr 27, 2023 21:03 UTC
MALONE JOHN CDirector · 10% owner
GrantShare Option A (right to buy) · Derivative 32,473 Not disclosed Strike: $35.69 Not disclosed
Disclosure

SEC source: 0001570585-23-000145 · wf-form4_168262940232649.xml · derivative · entry 4

MALONE JOHN C · CIK 0000937797 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,473

Underlying: Class A Ordinary Shares · 32,473 shares

Expires 2027-05-01

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

Read SEC document
April 25, 2023 Filed Apr 27, 2023 21:03 UTC
MALONE JOHN CDirector · 10% owner
Disposition to issuerShare Option A (right to buy) · Derivative 32,473 Not disclosed Strike: $35.69 Not disclosed
Disclosure

SEC source: 0001570585-23-000145 · wf-form4_168262940232649.xml · derivative · entry 3

MALONE JOHN C · CIK 0000937797 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Ordinary Shares · 32,473 shares

Expires 2024-05-01

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

Read SEC document
April 25, 2023 Filed Apr 27, 2023 21:03 UTC
MALONE JOHN CDirector · 10% owner
GrantShare Option A (right to buy) · Derivative 30,259 Not disclosed Strike: $32.81 Not disclosed
Disclosure

SEC source: 0001570585-23-000145 · wf-form4_168262940232649.xml · derivative · entry 2

MALONE JOHN C · CIK 0000937797 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,259

Underlying: Class A Ordinary Shares · 30,259 shares

Expires 2026-05-01

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

Read SEC document
April 25, 2023 Filed Apr 27, 2023 21:03 UTC
MALONE JOHN CDirector · 10% owner
Disposition to issuerShare Option A (right to buy) · Derivative 30,259 Not disclosed Strike: $32.81 Not disclosed
Disclosure

SEC source: 0001570585-23-000145 · wf-form4_168262940232649.xml · derivative · entry 1

MALONE JOHN C · CIK 0000937797 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Ordinary Shares · 30,259 shares

Expires 2023-05-01

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 21:52 UTC GrantClass C Share Fund Units · Derivative 916 Not disclosed Not disclosed
Disclosure

SEC source: 0001570585-23-000108 · wf-form4_168064513050389.xml · derivative · entry 5

WARGO J DAVID · CIK 0001082013 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,474

Underlying: Class C Ordinary Shares · 916 shares

Expires not disclosed

F3 · derivative.exercise_price: The share fund units represent the economic equivalent of one share of the corresponding class of the Issuer's ordinary shares. The share fund units confer no voting or other rights of stock ownership. The share fund units will be payable, in shares of the corresponding class of the Issuer's ordinary shares, in accordance with the Director Deferred Compensation Plan.

F4 · price: The share fund units represent the deferral of shares for a portion of the fees paid to the Reporting Person for his services as a director. The number of share fund units acquired is based on the closing prices of the Class A and Class C ordinary shares on March 31, 2023, with the value of any fractional shares deferred in cash.

F3 · derivative.exercise_date: The share fund units represent the economic equivalent of one share of the corresponding class of the Issuer's ordinary shares. The share fund units confer no voting or other rights of stock ownership. The share fund units will be payable, in shares of the corresponding class of the Issuer's ordinary shares, in accordance with the Director Deferred Compensation Plan.

F3 · derivative.expiration_date: The share fund units represent the economic equivalent of one share of the corresponding class of the Issuer's ordinary shares. The share fund units confer no voting or other rights of stock ownership. The share fund units will be payable, in shares of the corresponding class of the Issuer's ordinary shares, in accordance with the Director Deferred Compensation Plan.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 21:52 UTC GrantClass A Share Fund Units · Derivative 458 Not disclosed Not disclosed
Disclosure

SEC source: 0001570585-23-000108 · wf-form4_168064513050389.xml · derivative · entry 4

WARGO J DAVID · CIK 0001082013 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,737

Underlying: Class A Ordinary Shares · 458 shares

Expires not disclosed

F3 · derivative.exercise_price: The share fund units represent the economic equivalent of one share of the corresponding class of the Issuer's ordinary shares. The share fund units confer no voting or other rights of stock ownership. The share fund units will be payable, in shares of the corresponding class of the Issuer's ordinary shares, in accordance with the Director Deferred Compensation Plan.

F4 · price: The share fund units represent the deferral of shares for a portion of the fees paid to the Reporting Person for his services as a director. The number of share fund units acquired is based on the closing prices of the Class A and Class C ordinary shares on March 31, 2023, with the value of any fractional shares deferred in cash.

F3 · derivative.exercise_date: The share fund units represent the economic equivalent of one share of the corresponding class of the Issuer's ordinary shares. The share fund units confer no voting or other rights of stock ownership. The share fund units will be payable, in shares of the corresponding class of the Issuer's ordinary shares, in accordance with the Director Deferred Compensation Plan.

F3 · derivative.expiration_date: The share fund units represent the economic equivalent of one share of the corresponding class of the Issuer's ordinary shares. The share fund units confer no voting or other rights of stock ownership. The share fund units will be payable, in shares of the corresponding class of the Issuer's ordinary shares, in accordance with the Director Deferred Compensation Plan.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 21:52 UTC GrantClass C Ordinary Shares 140 $20.38 $2,853.20
Disclosure

SEC source: 0001570585-23-000108 · wf-form4_168064513050389.xml · nonDerivative · entry 2

WARGO J DAVID · CIK 0001082013 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 189,288

F1 · shares: Acquired in accordance with the terms of the Liberty Global 2014 Nonemployee Director Incentive Plan for the equity portion of the fees paid to the Reporting Person for his services as a director. The number of shares was determined using the closing market price of the applicable class of ordinary shares on March 31, 2023.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 21:52 UTC GrantClass A Ordinary Shares 70 $19.50 $1,365.00
Disclosure

SEC source: 0001570585-23-000108 · wf-form4_168064513050389.xml · nonDerivative · entry 1

WARGO J DAVID · CIK 0001082013 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,623

F1 · shares: Acquired in accordance with the terms of the Liberty Global 2014 Nonemployee Director Incentive Plan for the equity portion of the fees paid to the Reporting Person for his services as a director. The number of shares was determined using the closing market price of the applicable class of ordinary shares on March 31, 2023.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 21:52 UTC
COLE ANDREWDirector
GrantClass C Ordinary Shares 539 $20.38 $10,984.82
Disclosure

SEC source: 0001570585-23-000107 · wf-form4_168064511212091.xml · nonDerivative · entry 2

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,437

F1 · shares: Acquired in accordance with the terms of the Liberty Global 2014 Nonemployee Director Incentive Plan for the equity portion of the fees paid to the Reporting Person for his services as a director. The number of shares was determined using the closing market price of the applicable class of ordinary shares on March 31, 2023.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 21:52 UTC
COLE ANDREWDirector
GrantClass A Ordinary Shares 269 $19.50 $5,245.50
Disclosure

SEC source: 0001570585-23-000107 · wf-form4_168064511212091.xml · nonDerivative · entry 1

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,374

F1 · shares: Acquired in accordance with the terms of the Liberty Global 2014 Nonemployee Director Incentive Plan for the equity portion of the fees paid to the Reporting Person for his services as a director. The number of shares was determined using the closing market price of the applicable class of ordinary shares on March 31, 2023.

Read SEC document
March 30, 2023 Filed Mar 30, 2023 21:30 UTC
HALL BRYAN HEVP, Gen Counsel & Secretary
SaleClass C Ordinary Shares 6,000 $20.04 $120,248.40
Disclosure

SEC source: 0001570585-23-000099 · wf-form4_168021179868817.xml · nonDerivative · entry 2

HALL BRYAN H · CIK 0001292152 · EVP, Gen Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,497

Read SEC document
March 28, 2023 Filed Mar 30, 2023 21:30 UTC
HALL BRYAN HEVP, Gen Counsel & Secretary
SaleClass C Ordinary Shares 10,000 $19.77 $197,673.00
Disclosure

SEC source: 0001570585-23-000099 · wf-form4_168021179868817.xml · nonDerivative · entry 1

HALL BRYAN H · CIK 0001292152 · EVP, Gen Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,497

Read SEC document
March 24, 2023 Filed Mar 28, 2023 21:37 UTC GrantShare Appreciation Rights C · Derivative 288,350 $0.00 Strike: $19.38 $0.00
Disclosure

SEC source: 0001570585-23-000086 · wf-form4_168003942909579.xml · derivative · entry 4

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 288,350

Underlying: Class C Ordinary Shares · 288,350 shares

Expires 2033-03-24

F3 · derivative.exercise_date: The Share Appreciation Rights vest in three equal annual installments commencing on May 1, 2024.

Read SEC document
March 24, 2023 Filed Mar 28, 2023 21:37 UTC GrantShare Appreciation Rights A · Derivative 144,175 $0.00 Strike: $18.52 $0.00
Disclosure

SEC source: 0001570585-23-000086 · wf-form4_168003942909579.xml · derivative · entry 3

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,175

Underlying: Class A Ordinary Shares · 144,175 shares

Expires 2033-03-24

F3 · derivative.exercise_date: The Share Appreciation Rights vest in three equal annual installments commencing on May 1, 2024.

Read SEC document
March 24, 2023 Filed Mar 28, 2023 21:37 UTC GrantRestricted Share Units C · Derivative 106,840 Not disclosed Not disclosed
Disclosure

SEC source: 0001570585-23-000086 · wf-form4_168003942909579.xml · derivative · entry 2

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,840

Underlying: Class C Ordinary Shares · 106,840 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on May 1, 2024.

F2 · derivative.expiration_date: The RSUs vest in three equal annual installments commencing on May 1, 2024.

Read SEC document
March 24, 2023 Filed Mar 28, 2023 21:37 UTC GrantRestricted Share Units A · Derivative 53,420 Not disclosed Not disclosed
Disclosure

SEC source: 0001570585-23-000086 · wf-form4_168003942909579.xml · derivative · entry 1

BRACKEN CHARLES H R · CIK 0001091974 · EVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,420

Underlying: Class A Ordinary Shares · 53,420 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on May 1, 2024.

F2 · derivative.expiration_date: The RSUs vest in three equal annual installments commencing on May 1, 2024.

Read SEC document
March 24, 2023 Filed Mar 28, 2023 21:37 UTC
FRIES MICHAEL TDirector · President & CEO
GrantShare Appreciation Rights C · Derivative 1,504,272 $0.00 Strike: $19.38 $0.00
Disclosure

SEC source: 0001570585-23-000087 · wf-form4_168003945329936.xml · derivative · entry 2

FRIES MICHAEL T · CIK 0001058725 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,504,272

Underlying: Class C Ordinary Shares · 1,504,272 shares

Expires 2033-03-24

F3 · derivative.exercise_date: The Share Appreciation Rights vest in three equal annual installments commencing on May 1, 2024.

Read SEC document
March 24, 2023 Filed Mar 28, 2023 21:37 UTC
FRIES MICHAEL TDirector · President & CEO
GrantRestricted Share Units C · Derivative 556,566 Not disclosed Not disclosed
Disclosure

SEC source: 0001570585-23-000087 · wf-form4_168003945329936.xml · derivative · entry 1

FRIES MICHAEL T · CIK 0001058725 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 556,566

Underlying: Class C Ordinary Shares · 556,566 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on May 1, 2024.

F2 · derivative.expiration_date: The RSUs vest in three equal annual installments commencing on May 1, 2024.

Read SEC document
March 24, 2023 Filed Mar 28, 2023 21:39 UTC
Waldron JasonSVP & CAO
GrantShare Appreciation Rights C · Derivative 92,272 $0.00 Strike: $19.38 $0.00
Disclosure

SEC source: 0001570585-23-000091 · wf-form4_168003954554918.xml · derivative · entry 4

Waldron Jason · CIK 0001693396 · SVP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,272

Underlying: Class C Ordinary Shares · 92,272 shares

Expires 2033-03-24

F3 · derivative.exercise_date: The Share Appreciation Rights vest in three equal annual installments commencing on May 1, 2024.

Read SEC document
March 24, 2023 Filed Mar 28, 2023 21:39 UTC
Waldron JasonSVP & CAO
GrantShare Appreciation Rights A · Derivative 46,136 $0.00 Strike: $18.52 $0.00
Disclosure

SEC source: 0001570585-23-000091 · wf-form4_168003954554918.xml · derivative · entry 3

Waldron Jason · CIK 0001693396 · SVP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,136

Underlying: Class A Ordinary Shares · 46,136 shares

Expires 2033-03-24

F3 · derivative.exercise_date: The Share Appreciation Rights vest in three equal annual installments commencing on May 1, 2024.

Read SEC document
March 24, 2023 Filed Mar 28, 2023 21:39 UTC
Waldron JasonSVP & CAO
GrantRestricted Share Units C · Derivative 34,188 Not disclosed Not disclosed
Disclosure

SEC source: 0001570585-23-000091 · wf-form4_168003954554918.xml · derivative · entry 2

Waldron Jason · CIK 0001693396 · SVP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,188

Underlying: Class C Ordinary Shares · 34,188 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on May 1, 2024.

F2 · derivative.expiration_date: The RSUs vest in three equal annual installments commencing on May 1, 2024.

Read SEC document
March 24, 2023 Filed Mar 28, 2023 21:39 UTC
Waldron JasonSVP & CAO
GrantRestricted Share Units A · Derivative 17,094 Not disclosed Not disclosed
Disclosure

SEC source: 0001570585-23-000091 · wf-form4_168003954554918.xml · derivative · entry 1

Waldron Jason · CIK 0001693396 · SVP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,094

Underlying: Class A Ordinary Shares · 17,094 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on May 1, 2024.

F2 · derivative.expiration_date: The RSUs vest in three equal annual installments commencing on May 1, 2024.

Read SEC document
March 24, 2023 Filed Mar 28, 2023 21:38 UTC
HALL BRYAN HEVP, Gen Counsel & Secretary
GrantShare Appreciation Rights C · Derivative 196,078 $0.00 Strike: $19.38 $0.00
Disclosure

SEC source: 0001570585-23-000088 · wf-form4_168003947803598.xml · derivative · entry 4

HALL BRYAN H · CIK 0001292152 · EVP, Gen Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 196,078

Underlying: Class C Ordinary Shares · 196,078 shares

Expires 2033-03-24

F3 · derivative.exercise_date: The Share Appreciation Rights vest in three equal annual installments commencing on May 1, 2024.

Read SEC document
March 24, 2023 Filed Mar 28, 2023 21:38 UTC
HALL BRYAN HEVP, Gen Counsel & Secretary
GrantShare Appreciation Rights A · Derivative 98,039 $0.00 Strike: $18.52 $0.00
Disclosure

SEC source: 0001570585-23-000088 · wf-form4_168003947803598.xml · derivative · entry 3

HALL BRYAN H · CIK 0001292152 · EVP, Gen Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 98,039

Underlying: Class A Ordinary Shares · 98,039 shares

Expires 2033-03-24

F3 · derivative.exercise_date: The Share Appreciation Rights vest in three equal annual installments commencing on May 1, 2024.

Read SEC document
March 24, 2023 Filed Mar 28, 2023 21:38 UTC
HALL BRYAN HEVP, Gen Counsel & Secretary
GrantRestricted Share Units C · Derivative 72,652 Not disclosed Not disclosed
Disclosure

SEC source: 0001570585-23-000088 · wf-form4_168003947803598.xml · derivative · entry 2

HALL BRYAN H · CIK 0001292152 · EVP, Gen Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,652

Underlying: Class C Ordinary Shares · 72,652 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on May 1, 2024.

F2 · derivative.expiration_date: The RSUs vest in three equal annual installments commencing on May 1, 2024.

Read SEC document
March 24, 2023 Filed Mar 28, 2023 21:38 UTC
HALL BRYAN HEVP, Gen Counsel & Secretary
GrantRestricted Share Units A · Derivative 36,326 Not disclosed Not disclosed
Disclosure

SEC source: 0001570585-23-000088 · wf-form4_168003947803598.xml · derivative · entry 1

HALL BRYAN H · CIK 0001292152 · EVP, Gen Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,326

Underlying: Class A Ordinary Shares · 36,326 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on May 1, 2024.

F2 · derivative.expiration_date: The RSUs vest in three equal annual installments commencing on May 1, 2024.

Read SEC document
March 24, 2023 Filed Mar 28, 2023 21:38 UTC
Rodriguez EnriqueEVP, Chief Technology Officer
GrantShare Appreciation Rights C · Derivative 244,520 $0.00 Strike: $19.38 $0.00
Disclosure

SEC source: 0001570585-23-000089 · wf-form4_168003950796599.xml · derivative · entry 4

Rodriguez Enrique · CIK 0001565787 · EVP, Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 244,520

Underlying: Class C Ordinary Shares · 244,520 shares

Expires 2033-03-24

F3 · derivative.exercise_date: The Share Appreciation Rights vest in three equal annual installments commencing on May 1, 2024.

Read SEC document
March 24, 2023 Filed Mar 28, 2023 21:38 UTC
Rodriguez EnriqueEVP, Chief Technology Officer
GrantShare Appreciation Rights A · Derivative 122,260 $0.00 Strike: $18.52 $0.00
Disclosure

SEC source: 0001570585-23-000089 · wf-form4_168003950796599.xml · derivative · entry 3

Rodriguez Enrique · CIK 0001565787 · EVP, Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 122,260

Underlying: Class A Ordinary Shares · 122,260 shares

Expires 2033-03-24

F3 · derivative.exercise_date: The Share Appreciation Rights vest in three equal annual installments commencing on May 1, 2024.

Read SEC document
March 24, 2023 Filed Mar 28, 2023 21:38 UTC
Rodriguez EnriqueEVP, Chief Technology Officer
GrantRestricted Share Units C · Derivative 90,600 Not disclosed Not disclosed
Disclosure

SEC source: 0001570585-23-000089 · wf-form4_168003950796599.xml · derivative · entry 2

Rodriguez Enrique · CIK 0001565787 · EVP, Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,600

Underlying: Class C Ordinary Shares · 90,600 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on May 1, 2024.

F2 · derivative.expiration_date: The RSUs vest in three equal annual installments commencing on May 1, 2024.

Read SEC document
March 24, 2023 Filed Mar 28, 2023 21:38 UTC
Rodriguez EnriqueEVP, Chief Technology Officer
GrantRestricted Share Units A · Derivative 45,300 Not disclosed Not disclosed
Disclosure

SEC source: 0001570585-23-000089 · wf-form4_168003950796599.xml · derivative · entry 1

Rodriguez Enrique · CIK 0001565787 · EVP, Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,300

Underlying: Class A Ordinary Shares · 45,300 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on May 1, 2024.

F2 · derivative.expiration_date: The RSUs vest in three equal annual installments commencing on May 1, 2024.

Read SEC document
March 24, 2023 Filed Mar 28, 2023 21:39 UTC
Salvato AndreaEVP, CHIEF DEVELOPMENT OFFICER
GrantShare Appreciation Rights C · Derivative 276,816 $0.00 Strike: $19.38 $0.00
Disclosure

SEC source: 0001570585-23-000090 · wf-form4_168003952675185.xml · derivative · entry 4

Salvato Andrea · CIK 0001778743 · EVP, CHIEF DEVELOPMENT OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 276,816

Underlying: Class C Ordinary Shares · 276,816 shares

Expires 2033-03-24

F3 · derivative.exercise_date: The Share Appreciation Rights vest in three equal annual installments commencing on May 1, 2024.

Read SEC document
March 24, 2023 Filed Mar 28, 2023 21:39 UTC
Salvato AndreaEVP, CHIEF DEVELOPMENT OFFICER
GrantShare Appreciation Rights A · Derivative 138,408 $0.00 Strike: $18.52 $0.00
Disclosure

SEC source: 0001570585-23-000090 · wf-form4_168003952675185.xml · derivative · entry 3

Salvato Andrea · CIK 0001778743 · EVP, CHIEF DEVELOPMENT OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 138,408

Underlying: Class A Ordinary Shares · 138,408 shares

Expires 2033-03-24

F3 · derivative.exercise_date: The Share Appreciation Rights vest in three equal annual installments commencing on May 1, 2024.

Read SEC document
March 24, 2023 Filed Mar 28, 2023 21:39 UTC
Salvato AndreaEVP, CHIEF DEVELOPMENT OFFICER
GrantRestricted Share Units C · Derivative 102,566 Not disclosed Not disclosed
Disclosure

SEC source: 0001570585-23-000090 · wf-form4_168003952675185.xml · derivative · entry 2

Salvato Andrea · CIK 0001778743 · EVP, CHIEF DEVELOPMENT OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,566

Underlying: Class C Ordinary Shares · 102,566 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on May 1, 2024.

F2 · derivative.expiration_date: The RSUs vest in three equal annual installments commencing on May 1, 2024.

Read SEC document
March 24, 2023 Filed Mar 28, 2023 21:39 UTC
Salvato AndreaEVP, CHIEF DEVELOPMENT OFFICER
GrantRestricted Share Units A · Derivative 51,283 Not disclosed Not disclosed
Disclosure

SEC source: 0001570585-23-000090 · wf-form4_168003952675185.xml · derivative · entry 1

Salvato Andrea · CIK 0001778743 · EVP, CHIEF DEVELOPMENT OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,283

Underlying: Class A Ordinary Shares · 51,283 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F1 · price: Each Restricted Share Unit (RSU) represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on May 1, 2024.

F2 · derivative.expiration_date: The RSUs vest in three equal annual installments commencing on May 1, 2024.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.